产品展示
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
点击次数：165发布时间：2012/10/30 19:22:58
更新日期：2024/10/16 16:00:43
所 在 地：美洲
产品型号：
优质供应
详细内容
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
慧嘉生物您实验身边的好伙伴
为客户提供“质量的产品”和“*优质的服务”
欢迎广大客户咨询，另有大量宣传海报和小礼品赠送。
联系电话：
传 真：
Q Q：
邮 箱：sale@biohj.com
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
SERPINE1 Human/人纤溶酶原激活物抑制剂-1
产品编号：ENZ-356
产品规格：2μg/10μg/1mg
Synonyms PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. Introduction Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. Description Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation.
The SERPINE1 is purified by proprietary chromatographic techniques. Physical Appearance Sterile Filtered clear colorless solution. Formulation 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. Stability Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. Purity Greater than 95.0% as determined by（a） Analysis by RP-HPLC.
（b） Analysis by SDS-PAGE. Usage Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
产品规格：2μg/10μg/1mg
| Synonyms | PAI-1, PAI1, PLANH1, SERPINE1, PAIE, PLASMINOGEN ACTIVATOR INHIBITOR, BETA-MIGRATING ENDOTHELIAL-CELL-DERIVED TYPE. |
| Introduction | Plasminogen activator inhibitor-1 is the principal inhibitor of tissue plasminogen activator（tPA） ａnd urokinase（uPA）, the activators of plasminogenand hence fibrinolysis（the physiological breakdown of blood clots）. It is a serine protease inhibitor（serpin） protein （SERPINE1）. The other PAI, plasminogen activator inhibitor-2（PAI-2） is secreted by the placentaand only present in significant amounts during pregnancy. In addition, protease nexinacts as an inhibitor of tPA ａnd urokinase. PAI-1, however, is the main inhibitor of the plasminogen activators. |
| Description | Constitutively active human plasminogen activator inhibitor 1, stable mutant 14-1B having a Molecular mass of 43 kDa. This human form of SERPINE1 contains the following four mutations: K154T, Q139L, M354I ａnd N150H. These mutations combine to confer great stability to the otherwise labile molecule essentially locking it into the active conformation. The SERPINE1 is purified by proprietary chromatographic techniques. |
| Physical Appearance | Sterile Filtered clear colorless solution. |
| Formulation | 0.05M sodium phosphate 0.1M NaCl ａnd 1mM EDTA （pH 6.6）. |
| Stability | Human SERPINE1 although stable at 8°C celsius for 1 week, should be stored desiccated below -18°C. |
| Purity | Greater than 95.0% as determined by（a） Analysis by RP-HPLC. （b） Analysis by SDS-PAGE. |
| Usage | Prospec＇s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals. |
